BioNexus Gene Lab Corp

BGLC

Company Profile

  • Business description

    BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

  • Contact

    No.5 Jln Bangsar Utama 1
    Unit A-28-7, Level 28, Tower A
    Menara UOA Bangsar
    Kuala LumpurSGR59200
    MYS

    T: +60 3072416898

    https://www.bionexusgenelab.com

  • Sector

    Basic Materials

    Stock type

    Cyclical

  • Industry

    Specialty Chemicals

    Fiscal Year End

    31 December 2025

    Employees

    1

Stocks News & Analysis

stocks

Ask the analyst: Are Qantas shares a value trap?

Qantas’ pandemic woes seem a distant memory. But could the party end sooner than investors think?
stocks

Palantir earnings: Blockbuster growth amid high expectations

We raise our fair value estimate off the back of earnings.
stocks

ResMed earnings: Solid showing from ASX healthcare winner

Strong demand growth and improved profit margins lead to a strong result from the sleep apnea device firm.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,111.1082.300.91%
CAC 407,635.0313.990.18%
DAX 4023,924.3678.290.33%
Dow JONES (US)44,193.1281.380.18%
FTSE 1009,164.3121.580.24%
HKSE24,910.638.100.03%
NASDAQ21,169.42252.871.21%
Nikkei 22540,794.86245.320.60%
NZX 50 Index12,924.0343.870.34%
S&P 5006,345.0645.870.73%
S&P/ASX 2008,843.7073.300.84%
SSE Composite Index3,633.9916.400.45%

Market Movers